- Dr Herrera on the Significance of the FDA Approval of Nivolumab Plus AVD for Classical Hodgkin LymphomaAlex Herrera, MD, discusses the FDA approval of nivolumab plus AVD for classical Hodgkin lymphoma and its impact on clinical practice.onclive · 2mo ago↗ source
- Dr Sznol on Biomarkers of Response in Metastatic MelanomaMario Sznol, MD, discusses the uncertainties around predicting benefit with immune checkpoint inhibitors in metastatic melanoma.onclive · 2mo ago↗ source
- Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and DiscoveryThe State of Utah has made a visionary investment in AI and advanced computing infrastructure to advance research.onclive · 2mo ago